The Discounted Cash Flow (DCF) valuation of Quest Diagnostics Inc (DGX) is 206.54 USD. With the latest stock price at 175.90 USD, the upside of Quest Diagnostics Inc based on DCF is 17.4%.
Based on the latest price of 175.90 USD and our DCF valuation, Quest Diagnostics Inc (DGX) is a buy. buying DGX stocks now will result in a potential gain of 17.4%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.5% | 6.6% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 161.28 - 278.87 | 206.54 |
| Upside | -8.3% - 58.5% | 17.4% |